Previous studies suggested that the activated PI3K/AKT/mTOR signaling pathway can promote cell survival and cancer cell growth by attenuating apoptosis-related signaling, and this effect can result in radiotherapy resistance [51]. The gene discussed is MTOR; the disease is cancer.